Kayne Anderson Rudnick Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.6M | Buy |
160,683
+15,536
| +11% | +$1.25M | 0.04% | 213 |
|
|
2026
Q1 | $12.6M | Buy |
145,147
+3,387
| +2% | +$324K | 0.04% | 217 |
|
|
2025
Q4 | $13.6M | Sell |
141,760
-2,096
| -1% | -$204K | 0.04% | 216 |
|
|
2025
Q3 | $13.7M | Sell |
143,856
-1,463
| -1% | -$134K | 0.03% | 220 |
|
|
2025
Q2 | $12.7M | Buy |
145,319
+125,447
| +631% | +$10.6M | 0.03% | 219 |
|
|
2025
Q1 | $1.79M | Sell |
19,872
-3,419
| -15% | -$306K | ﹤0.01% | 346 |
|
|
2024
Q4 | $1.86M | Sell |
23,291
-3,462
| -13% | -$300K | ﹤0.01% | 352 |
|
|
2024
Q3 | $2.41M | Sell |
26,753
-3,720
| -12% | -$313K | 0.01% | 328 |
|
|
2024
Q2 | $2.4M | Sell |
30,473
-29,179
| -49% | -$2.39M | 0.01% | 321 |
|
|
2024
Q1 | $5.2M | Sell |
59,652
-6,305
| -10% | -$538K | 0.01% | 291 |
|
|
2023
Q4 | $5.43M | Buy |
65,957
+11,718
| +22% | +$893K | 0.01% | 284 |
|
|
2023
Q3 | $4.25M | Sell |
54,239
-937
| -2% | -$78.4K | 0.01% | 298 |
|
|
2023
Q2 | $4.86M | Sell |
55,176
-2,541
| -4% | -$219K | 0.01% | 294 |
|
|
2023
Q1 | $4.65M | Buy |
57,717
+14,685
| +34% | +$1.2M | 0.01% | 296 |
|
|
2022
Q4 | $3.34M | Sell |
43,032
-9,266
| -18% | -$751K | 0.01% | 316 |
|
|
2022
Q3 | $4.22M | Buy |
52,298
+955
| +2% | +$85.8K | 0.01% | 294 |
|
|
2022
Q2 | $4.61M | Sell |
51,343
-1,401
| -3% | -$142K | 0.01% | 287 |
|
|
2022
Q1 | $5.85M | Buy |
52,744
+17,543
| +50% | +$1.85M | 0.02% | 268 |
|
|
2021
Q4 | $3.64M | Sell |
35,201
-9,368
| -21% | -$1.08M | 0.01% | 294 |
|
|
2021
Q3 | $5.59M | Buy |
44,569
+1,809
| +4% | +$234K | 0.01% | 266 |
|
|
2021
Q2 | $5.31M | Buy |
42,760
+2,130
| +5% | +$267K | 0.01% | 264 |
|
|
2021
Q1 | $4.8M | Buy |
40,630
+1,067
| +3% | +$125K | 0.01% | 257 |
|
|
2020
Q4 | $4.63M | Buy |
39,563
+13,949
| +54% | +$1.54M | 0.01% | 259 |
|
|
2020
Q3 | $2.66M | Buy |
25,614
+24,902
| +3,497% | +$2.5M | 0.01% | 267 |
|
|
2020
Q2 | $65K | Hold |
712
| – | – | ﹤0.01% | 391 |
|
|
2020
Q1 | $64K | Hold |
712
| – | – | ﹤0.01% | 385 |
|
|
2019
Q4 | $81K | Buy |
712
+23
| +3% | +$2.52K | ﹤0.01% | 374 |
|
|
2019
Q3 | $75K | Buy |
689
+15
| +2% | +$1.56K | ﹤0.01% | 366 |
|
|
2019
Q2 | $66K | Buy |
+674
| New | +$61.5K | ﹤0.01% | 361 |
|
|
2018
Q1 | – | Sell |
-151,984
| Closed | -$12.3M | – | 353 |
|
|
2017
Q4 | $12.3M | Sell |
151,984
-2,581
| -2% | -$207K | 0.1% | 162 |
|
|
2017
Q3 | $12M | Sell |
154,565
-2,232
| -1% | -$185K | 0.11% | 165 |
|
|
2017
Q2 | $13.9M | Sell |
156,797
-3,809
| -2% | -$321K | 0.14% | 154 |
|
|
2017
Q1 | $12.9M | Sell |
160,606
-14,429
| -8% | -$1.13M | 0.14% | 158 |
|
|
2016
Q4 | $12.5M | Sell |
175,035
-16,220
| -8% | -$1.27M | 0.15% | 156 |
|
|
2016
Q3 | $16.5M | Sell |
191,255
-5,420
| -3% | -$472K | 0.21% | 137 |
|
|
2016
Q2 | $17.1M | Sell |
196,675
-3,236
| -2% | -$262K | 0.26% | 111 |
|
|
2016
Q1 | $15M | Sell |
199,911
-7,727
| -4% | -$582K | 0.24% | 116 |
|
|
2015
Q4 | $16M | Sell |
207,638
-8,749
| -4% | -$659K | 0.26% | 105 |
|
|
2015
Q3 | $14.5M | Sell |
216,387
-15,694
| -7% | -$1.16M | 0.25% | 105 |
|
|
2015
Q2 | $17.2M | Buy |
232,081
+2,569
| +1% | +$196K | 0.27% | 101 |
|
|
2015
Q1 | $17.9M | Buy |
+229,512
| New | +$17.4M | 0.28% | 96 |
|
Other funds holding MDT
Kayne Anderson Rudnick Investment Management's MDT Position: Q2 2026 in Review
Kayne Anderson Rudnick Investment Management increased its Medtronic (MDT) stake by 11% in Q2 2026, buying an estimated $1.25M and bringing the position to 160,683 shares worth $12.6M. The position accounts for 0.04% of the portfolio, ranked #213.
Kayne Anderson Rudnick Investment Management first reported a position in MDT in Q1 2015 and has held it in 41 quarters since. The position peaked at $17.9M in Q1 2015. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Kayne Anderson Rudnick Investment Management held 160,683 shares of Medtronic worth $12.6M as of Q2 2026.
- Kayne Anderson Rudnick Investment Management bought 15,536 Medtronic shares in Q2 2026, an estimated $1.25M.
- Medtronic made up 0.04% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #213 holding.
- Kayne Anderson Rudnick Investment Management first reported a position in Medtronic in Q1 2015 and has held it in 41 quarters since.
- Kayne Anderson Rudnick Investment Management's Medtronic position peaked at $17.9M in Q1 2015.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.